Document is current

Any future updates will be listed below

Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate: results of a phase III trial

Crossref DOI link: https://doi.org/10.1186/s13075-016-1096-9

Published Online: 2016-09-06

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark